deferoxamine has been researched along with Lung Diseases, Interstitial in 3 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyakawa, H | 1 |
| Mason, RP | 1 |
| Jiang, J | 1 |
| Kadiiska, MB | 1 |
| Wang, XJ | 1 |
| Yin, QS | 1 |
| Wei, XD | 1 |
| Rego, EM | 1 |
| Neto, EB | 1 |
| Simões, BP | 1 |
| Zago, MA | 1 |
1 review available for deferoxamine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
[Deferoxamine-induced interstitial pulmonary injury: a case report and literature review].
Topics: Adult; Deferoxamine; Humans; Lung Diseases, Interstitial; Male; Myelodysplastic Syndromes | 2012 |
2 other studies available for deferoxamine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Lipid-derived free radical production in superantigen-induced interstitial pneumonia.
Topics: Allopurinol; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Cell Movement; Deferoxamine; | 2009 |
Dose-dependent pulmonary syndrome in patients with thalassemia major receiving intravenous deferoxamine.
Topics: Adolescent; beta-Thalassemia; Child; Deferoxamine; Dose-Response Relationship, Drug; Female; Humans; | 1998 |